Equities researchers at Barclays started coverage on shares of Corteva (NYSE:CTVA – Get Free Report) in a research report issued to clients and investors on Thursday, MarketBeat.com reports. The brokerage set an “equal weight” rating and a $11.00 price target on the stock. Barclays‘s price target indicates a potential upside of 39.42% from the stock’s previous close.
Other research analysts also recently issued reports about the stock. Mizuho set a $16.00 target price on shares of Corteva in a research report on Thursday, November 12th. Argus reaffirmed a “buy” rating and issued a $91.00 price target on shares of Corteva in a report on Friday, September 18th. Citigroup cut their price target on Corteva from $13.65 to $10.30 and set a “neutral” rating on the stock in a research report on Friday, November 13th. KeyCorp reduced their price objective on Corteva from $17.00 to $14.00 and set an “overweight” rating for the company in a research note on Monday, November 16th. Finally, Zacks Research cut Corteva from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 6th. Fourteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $48.83.
Read Our Latest Stock Analysis on Corteva
Corteva Stock Down 2.8%
Insider Buying and Selling
In other news, CEO Luther C. Iv Kissam acquired 32,292 shares of the business’s stock in a transaction on Friday, November 13th. The stock was bought at an average price of $9.30 per share, with a total value of $300,315.60. Following the completion of the acquisition, the chief executive officer owned 185,379 shares of the company’s stock, valued at approximately $1,724,024.70. This represents a 21.09% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.15% of the company’s stock.
Institutional Investors Weigh In On Corteva
Hedge funds have recently modified their holdings of the company. BlackRock Inc. purchased a new stake in shares of Corteva during the 2nd quarter valued at approximately $4,560,180,000. Wellington Management Group LLP grew its holdings in shares of Corteva by 941.7% during the 2nd quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock worth $644,720,000 after purchasing an additional 6,881,875 shares during the period. Royal Bank of Canada increased its position in shares of Corteva by 202.1% during the 1st quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock worth $624,362,000 after purchasing an additional 4,989,371 shares during the last quarter. Jupiter Topco LLC purchased a new stake in Corteva in the 2nd quarter valued at about $544,246,000. Finally, Bank of America Corp DE purchased a new stake in Corteva in the 2nd quarter valued at about $484,927,000. 81.54% of the stock is owned by hedge funds and other institutional investors.
Corteva Company Profile
Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.
Recommended Stories
- Five stocks we like better than Corteva
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
